Evidence map›Paper›PMID 31159153›Full record

ReviewMolecules (Basel, Switzerland)2019

A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress.

Tyler W LeBaron, Branislav Kura, Barbora Kalocayova, Narcis Tribulova, Jan Slezak

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04716985 (Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study), which is not on this map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04716985 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study

TypeinterventionalSponsorAGIR à DomRan2021 to 2023Enrolled700ConditionsSARS-CoV-2, Covid19, AMBULATORY CAREArmsMOLECULAR HYDROGEN, PLACEBO MAGNESIUM
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Progress in the Application of Molecular Hydrogen in Medical Skin Cosmetology.Clinical, cosmetic and investigational dermatology · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. HAntimicrobial agents and chemotherapy · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tyler W LeBaronCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava 841 04, Slovak Republic. LeBaronT@molecularhydrogeninstitute.com.ORCID 0000-0001-9164-6728
Branislav KuraCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava 841 04, Slovak Republic. branislav.kura@savba.sk.
Barbora KalocayovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava 841 04, Slovak Republic. barbora.kalocayova@savba.sk.
Narcis TribulovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava 841 04, Slovak Republic. narcisa.tribulova@savba.sk.
Jan SlezakCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, Bratislava 841 04, Slovak Republic. jan.slezak@savba.sk.
Slovak Academy of Sciences · SK

Funding

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR ITMS 26230120009Agentúra na Podporu Výskumu a Vývoja APVV-0241-11Agentúra na Podporu Výskumu a Vývoja APVV-15-0376Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0063/18
6 · The paper itself

Abstract

Cardiovascular diseases are the most common causes of morbidity and mortality worldwide. Redox dysregulation and a dyshomeostasis of inflammation arise from, and result in, cellular aberrations and pathological conditions, which lead to cardiovascular diseases. Despite years of intensive research, there is still no safe and effective method for their prevention and treatment. Recently, molecular hydrogen has been investigated in preclinical and clinical studies on various diseases associated with oxidative and inflammatory stress such as radiation-induced heart disease, ischemia-reperfusion injury, myocardial and brain infarction, storage of the heart, heart transplantation, etc. Hydrogen is primarily administered via inhalation, drinking hydrogen-rich water, or injection of hydrogen-rich saline. It favorably modulates signal transduction and gene expression resulting in suppression of proinflammatory cytokines, excess ROS production, and in the activation of the Nrf2 antioxidant transcription factor. Although H

Indexed as

AnimalsCardiovascular DiseasesCombined Modality TherapyHumansHydrogenOxidation-ReductionOxidative StressRadiation InjuriesReactive Oxygen SpeciesTreatment OutcomeHydrogenReactive Oxygen Speciesheart transplantationischemia/reperfusion injurymolecular hydrogenoxidative stressradiation-induced heart disease

Identifiers

PMID31159153
PMCPMC6600250
OpenAlexW2947727992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.